Stock Price Quote

MYLAN LABORATORIES LTD.

NSE : NABSE : 524794ISIN CODE : INE604D01023Industry : Pharmaceuticals & DrugsHouse : MNC
BSE209.350 (0 %)
PREV CLOSE ( ) 209.35
OPEN PRICE ( ) 208.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 209.35 (2)
VOLUME 50392
TODAY'S LOW / HIGH ( )208.80 211.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 29-11 1984
Management Info
- Chairman Rakesh Bamzai - Managing Director
Registered Office

Address Plot No. 564/ A/22,Road No. 92,Jubilee Hills,
Hyderabad,
Telangana-500033

Phone +91-040- 27700363/30496666/30494444

Email nagaraj.bodige@mylan.in

Website www.matrixlabsindia.com

Registrars Details
Venture Capital & Corporate Investments Ltd
Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57,4th & 5th Floors,Jayabheri Enclave Phase - II, Gachibowli,Hyderabad
Listing :

NEWS

09Nov Pfizer, Ashok Leyland and Adani Enterp
Pfizer has received two process patents related to its blockbuster drug..
21Sep Matrix Laboratories gets US health reg
Matrix Laboratories, an Indian subsidiary of Mylan Inc has received tent..
21Sep Matrix Labs gets US nod for generic AI
MylanInc’s Indian subsidiary Matrix Laboratories had received tentative..
24Sep Matrix Laboratories gets USFDA nod for
Matrix Laboratories (MLL) has got the approval from the U S Food and Dru..
23Sep Court asks Matrix not to sell generic
The Madras High Court has asked Matrix Laboratories not to make or sell..

Financials

in Millions
QTR Jun 09 ANNUAL 09
Net Profit165.61889.5
Gross Profit 268.4 2569.7
Operating Profit 491.43494.7
Net Sales 4099.915021.4

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Glaxosmithkline Phar (BSE)
peergroup  2671.75 (5.24%)
M.Cap ( in Cr)43006.26
Neuland Laboratories (BSE)
peergroup  6663.40 (1.55%)
M.Cap ( in Cr)8418.52
Astrazeneca Pharma I (BSE)
peergroup  6432.55 (1.28%)
M.Cap ( in Cr)15760.38
Mercury Laboratories (BSE)
peergroup  933.00 (5.78%)
M.Cap ( in Cr)105.84
Pfizer (BSE)
peergroup  4669.95 (0.67%)
M.Cap ( in Cr)21221.69

Shareholding Pattern

PROMOTERS 0%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
NON-INSTITUTION 0%

About Mylan Laboratories Ltd.

Mylan Laboratories Ltd. was incorporated in the year 1984. Its today's share price is 209.35. Its current market capitalisation stands at Rs 3272.95 Cr. In the latest quarter, company has reported Gross Sales of Rs. 122385.73 Cr and Total Income of Rs.124853.5 Cr. The company's management includes B Nagaraj Goud, Mohit Saraf, Rajiv Krishan Luthra, Sarada Kalyani Bhagawati, Rakesh Bamzai, Rajiv Malik.

It is listed on the BSE with a BSE Code of 524794 , NSE with an NSE Symbol of MATRIXLABS and ISIN of INE604D01023. It's Registered office is at Plot No. 564/ A/22,Road No. 92,Jubilee HillsHyderabad-500033, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Associates LLP, Deloitte Haskins & Sells, Deloittee Haskins & Sells

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.